BIOTRICITY INC.
BTCYOTCHealthcare · Surgical & Medical Instruments & Apparatus · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $13.8M | $12.1M | $9.6M | $7.7M | $3.4M | $1.4M |
| Operating income | −$2.4M | −$8.8M | −$15.4M | −$16.7M | — | — |
| Net income | −$8.4M | −$14.1M | −$18.7M | −$29.1M | −$15.5M | −$11.1M |
| Total assets | $5.6M | $5.9M | $6.5M | $16.7M | $4.4M | $2.0M |
| Total liabilities | $35.7M | $35.9M | $26.4M | $18.8M | $11.3M | $5.0M |
| Equity | −$32.0M | −$31.5M | −$19.8M | −$2.1M | −$6.8M | −$3.0M |
| EPS (diluted) | $-0.56 | $-1.66 | $-2.26 | $-0.67 | $-0.44 | — |
| Shares out. | 26.6M | 21.5M | 51.0M | 50.3M | 37.9M | 33.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −17.8%
- Net margin
- −61.1%
- Return on equity
- 26.3%
- Return on assets
- −149.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 632.1%
- Debt / equity
- —
- Book value / share
- $-1.21
- Revenue growth (YoY)
- 14.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -103.05distress
- Accruals / assets
- −107.1%clean
- Beneish M-Score
- -7.53normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jul 1, 2025
- NT 10-Qmissed a reporting deadline ↗Feb 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
- NT 10-Qmissed a reporting deadline ↗Feb 14, 2024
- NT 10-Kmissed a reporting deadline ↗Jun 29, 2022
- NT 10-Qmissed a reporting deadline ↗Aug 17, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Ionic Ventures, LlcPassive (13G)May 12, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 126,366 | 1.0 | +1.0% |
| Apr 30, 2026 | 125,158 | 2.4 | -4.1% |
| Apr 15, 2026 | 130,545 | 3.0 | +3.0% |
| Mar 31, 2026 | 126,794 | 1.0 | -1.4% |
| Mar 13, 2026 | 128,643 | 2.5 | -5.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity sale · Amended charter or bylawsMay 1, 2026
- Results of operationsFeb 18, 2026
- Results of operationsNov 18, 2025
- Results of operationsFeb 24, 2025
- Results of operationsNov 20, 2024
- Shareholder voteAug 16, 2024
- Delisting / listing-standard noticeAug 7, 2024
- Delisting / listing-standard noticeAug 1, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- PRE 14CMay 29, 2026
- SCHEDULE 13G/AMay 12, 2026
- 8-KMay 1, 2026
- 8-KFeb 18, 2026
- 10-QFeb 11, 2026
- SCHEDULE 13G/AFeb 4, 2026
- S-1Dec 19, 2025
- 8-KNov 18, 2025
- SCHEDULE 13G/ANov 14, 2025
- 10-QNov 14, 2025
- 10-QAug 14, 2025
- SCHEDULE 13G/AAug 12, 2025
- 10-K/AJul 18, 2025
- 10-KJul 15, 2025
- NT 10-KJul 1, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.